Companies / Kymera Therapeutics, Inc. / Activity
Activity — Kymera Therapeutics, Inc.
10 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Mainolfi Nello CEO | Sell | Common Stock | $748 | -8 -0.00% | 666,195 0.80% of shares | low |
| Feb 25, 2026 | Mainolfi Nello CEO | Exercise | Common Stock | $62.4K | +30K +4.50% | 696,195 0.84% of shares | low |
| Jan 5, 2026 | Mainolfi Nello CEO | Exercise | Common Stock | $100.0K | +3K +0.47% | 666,195 0.80% of shares | low |
| Feb 25, 2026 | Mainolfi Nello CEO | Sell | Common Stock | $139.3K | -2K -0.22% | 666,203 0.80% of shares | medium |
| Feb 25, 2026 | Mainolfi Nello CEO | Sell | Common Stock | $302.2K | -3K -0.49% | 667,704 0.80% of shares | medium |
| Feb 25, 2026 | Mainolfi Nello CEO | Sell | Common Stock | $491.2K | -5K -0.80% | 670,997 0.81% of shares | medium |
| Feb 25, 2026 | Mainolfi Nello CEO | Sell | Common Stock | $1.77M | -20K -2.84% | 676,431 0.81% of shares | medium |
| Mar 2, 2026 | Mainolfi Nello CEO | Grant | Stock Option (Right to Buy) | — | +215K | 215,000 0.26% of shares | low |
| Feb 25, 2026 | Mainolfi Nello CEO | Exercise | Stock Option (Right to Buy) | — | -30K -10.89% | 245,559 0.30% of shares | low |
| Jan 5, 2026 | Mainolfi Nello CEO | Exercise | Stock Option (Right to Buy) | — | -3K -0.69% | 446,882 0.54% of shares | low |